Phase II Study of Metformin for Reduction of Obesity-Associated Breast Cancer Risk

Clinical trial NCT02028221 · COMPLETED

Trial details

NCT number

NCT02028221

Sponsor

University of Arizona

Status

COMPLETED

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2014-03-07

Primary completion

2018-11-30

Enrollment

151

View on ClinicalTrials.gov